"I was sleeping for much of the time and didn't notice the nausea," she says
Before touching on the clinical trial results, its essential to understand each of these medications acts on one, some, or all of the following receptors: GLP1R, GIPR, and glucagon-R
The AI-powered system at Doctronic also provides free initial assessments, helping you understand your symptoms before speaking with a doctor
However, based on preclinical data and early human trial findings, glucagon receptor co-activation in the context of concurrent GLP-1R and GIPR agonism is hypothesised to: Increase energy expenditure, potentially by promoting thermogenesis Enhance hepatic fat oxidation, which may reduce liver fat content Contribute to appetite suppression through central nervous system pathways These GCGR-mediated mechanisms are largely derived from preclinical and indirect human data and require confirmation in larger trials
Store the lyophilized vial at 20 C, protected from light